Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Shares Issued (2016 - 2025)

Lipocine's Shares Issued history spans 11 years, with the latest figure at $141334.0 for Q3 2025.

  • For Q3 2025, Shares Issued changed N/A year-over-year to $141334.0; the TTM value through Sep 2025 reached $136035.0, down 67.28%, while the annual FY2024 figure was $209340.0, 48.26% down from the prior year.
  • Shares Issued reached $141334.0 in Q3 2025 per LPCN's latest filing, up from -$5299.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $26.8 million in Q1 2021 to a low of -$26.8 million in Q2 2021.
  • Average Shares Issued over 4 years is $96692.5, with a median of $73339.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: tumbled 99.23% in 2022, then surged 7779.53% in 2023.
  • A 4-year view of Shares Issued shows it stood at -$26.8 million in 2021, then skyrocketed by 100.02% to $5344.0 in 2022, then plummeted by 199.16% to -$5299.0 in 2023, then surged by 2767.18% to $141334.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Shares Issued are $141334.0 (Q3 2025), -$5299.0 (Q4 2023), and $421082.0 (Q3 2023).